# Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)

> **NCT00953680** · PHASE1 · COMPLETED · sponsor: **Organon and Co** · enrollment: 77 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** losartan potassium (+) hydrochlorothiazide (HCTZ)
- **DRUG:** losartan potassium
- **DRUG:** hydrochlorothiazide (HCTZ)

## Key facts

- **NCT ID:** NCT00953680
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2004-05
- **Final completion:** 2004-07
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00953680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00953680, "Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00953680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*